MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+39.14%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$305M
AUM Growth
+$305M
(-0.98%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-39.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
14
New
–
Increased
–
Reduced
2
Closed
6
Top Buys
No buys this quarter
Top Sells
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$105M |
| 2 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$8.12M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$5.34M |
| 4 |
Savara
SVRA
|
$1.2M |
| 5 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$178K |
Sector Composition
| 1 | Healthcare | 25.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
| $210M | 68.88% | 3,887,502 -1,943,751 | -33% | -$105M |
|
2
Syndax Pharmaceuticals
SNDX
$1.41B
| $32.9M | 10.77% | 2,168,691 | – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $17M | 5.58% | 1,729,674 | – | – |
|
|
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $16.9M | 5.52% | 5,736,296 | – | – |
|
|
ELGX
5
DELISTED
Endologix Inc
ELGX
| $14.4M | 4.7% | 1,121,447 | – | – |
|
6
Protara Therapeutics
TARA
$120M
| $9.18M | 3.01% | 983,381 | – | – |
|
|
HSTO
7
DELISTED
Histogen Inc. Common Stock
HSTO
| $2.38M | 0.78% | 1,192,080 | – | – |
|
|
PETX
8
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.34M | 0.77% | 250,000 -867,875 | -78% | -$8.12M |
|
9
MacroGenics
MGNX
$112M
| – | – | -3,168 | Closed | -$86K |
|
10
Sangamo Therapeutics
SGMO
$157M
| – | – | -22,487 | Closed | -$130K |
|
|
11
Savara
SVRA
$567M
| – | – | -2,551,851 | Closed | -$1.2M |
|
|
NVRO
12
DELISTED
NEVRO CORP.
NVRO
| – | – | -72,413 | Closed | -$5.34M |
|
|
CLCD
13
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| – | – | -21,806 | Closed | -$178K |
|